Last quarter (Q ), Acura Pharmaceuticals's total revenue was $36.00K, a decrease of -94.99% from the same quarter last year. In Q, Acura Pharmaceuticals's net income was $29.00K. See Acura Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 1.56M	$ 1.56M	$ 3.57M	$ 2.66M	$ 410.00K	$ 2.97M
Cost of Revenue	-	-	-	-	$ 0.00	$ 128.00K
Gross Profit	$ 306.00K	$ 1.56M	$ 3.57M	-	$ 410.00K	$ 2.84M
Operating Expense	$ 2.78M	$ 2.78M	$ 4.33M	$ 3.38M	$ 4.33M	$ 8.06M
Operating Income	$ -1.21M	$ -1.21M	$ -758.00K	$ -725.00K	$ -3.92M	$ -5.22M
Net Non Operating Interest Income Expense	$ 335.00K	$ 335.00K	$ -450.00K	$ -449.00K	$ -223.00K	$ -592.00K
Other Income Expense	-	-	-	$ -2.60M	$ 296.00K	-
Pretax Income	$ -879.00K	$ -879.00K	$ -1.21M	$ -3.77M	$ -3.84M	$ -5.82M
Tax Provision	$ -97.00K	$ -97.00K	-	$ 0.00	$ 0.00	$ -135.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -879.00K	$ -879.00K	$ -1.21M	$ -3.77M	$ -3.84M	$ -5.68M
Basic EPS	$ -0.02	$ -0.02	$ -0.04	$ -0.14	$ -0.18	$ -0.36
Diluted EPS	$ -0.02	$ -0.02	$ -0.04	$ -0.14	$ -0.18	$ -0.36
Basic Average Shares	$ 207.72M	$ 56.80M	$ 32.32M	$ 26.72M	$ 21.15M	$ 15.90M
Diluted Average Shares	$ 207.72M	$ 56.80M	$ 32.32M	$ 26.72M	$ 21.15M	$ 15.90M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 2.78M	$ 2.78M	$ 4.33M	$ 3.38M	$ 4.33M	$ 8.19M
Net Income From Continuing And Discontinued Operation	$ -879.00K	$ -879.00K	$ -1.21M	$ -3.77M	$ -3.84M	$ -5.68M
Normalized Income	$ -646.00K	-	-	$ -1.17M	$ -4.14M	$ -5.68M
Interest Expense	$ 200.00K	-	-	$ 462.00K	$ 395.00K	$ 596.00K
EBIT	$ -679.00K	$ -679.00K	$ -758.00K	$ -3.31M	$ -3.45M	$ -5.22M
EBITDA	$ -589.00K	$ -589.00K	$ -633.00K	$ -3.04M	$ -3.17M	$ -4.93M

Currency in USD

Acura Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing